Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1146/week)
Manufacturing
(552/week)
Energy
(450/week)
Technology
(1056/week)
Other Manufacturing
(345/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
BPH
Apr 06, 2020
The iTind Device Receives FDA de Novo Classification Order for Benign Prostatic Hyperplasia (BPH) Non-Surgical Treatment Device
Feb 18, 2020
Asheville Urological Associates Now Offers Innovative Rez m(TM) Water Vapor Therapy to Treat Benign Prostatic Hyperplasia (BPH), or Enlarged Prostate
Nov 26, 2019
Dr. David Samadi of RoboticOncology explains why Urolift is one of many options for BPH
Aug 13, 2019
Corinth MedTech Appoints Steven Duddy as New President and CEO
Jul 02, 2019
ProArc Medical Awarded $2.2 Million European Union Grant
Jun 21, 2019
Benign Prostatic Hyperplasia (BPH) Markets to 2027 - There Have Been 3 Licensing & Asset Acquisition Deals Involving BPH Drugs During 2013-2018
Jan 25, 2019
New Four-Year Data Demonstrate Rez m(TM) Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms
Nov 27, 2018
Square 1 Bank Announces Credit Facility to Zenflow
Jul 24, 2018
Medi-Tate Ltd., Announces the Enrollment of the First Fifty Patients in its Second Multi-center European Study on iTind
Jul 12, 2018
Global Benign Prostatic Hyperplasia Therapeutics Market Expected to Reach $20,097 Million by 2025 | Allied Market Research
Mar 13, 2018
DSS Urology's Dr. David S. Schnapp Receives Recognition as Rez m(R) Center of Excellence for Expertise in BPH Treatment
Feb 20, 2018
NxThera Announces Rez m(R) Center of Excellence Program Recognizing Top Urologists for Expertise in BPH Treatment
Jan 18, 2018
Newly Published Economic Analysis Finds NxThera's Minimally Invasive Rez m(R) System Provides Cost-Effective Solution to Treat BPH
Nov 28, 2017
Global Benign Prostatic Hyperplasia (BPH) Procedures Analysis 2013 - 2023
Oct 03, 2017
Vantia Therapeutics Announces Positive Results From its Phase III EQUINOC Study, a Pivotal Trial with Fedovapagon for the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia
Sep 28, 2017
Global Benign Prostatic Hyperplasia and Prostatitis Device-based Treatments Market 2016-2021
Sep 27, 2017
PROCEPT BioRobotics Announces First Patients Treated in WATER II Pivotal Clinical Trial
Sep 26, 2017
Olympus Bipolar TURP with Plasma Resection Study Demonstrates Procedure Cost-Savings Compared to Monopolar TURP
Latest News
Jul 18, 2025
L3Harris Announces Quarterly Dividend
Jul 18, 2025
ParkOhio Prices $350 Million Senior Secured Notes Offering
Jul 18, 2025
Graco Inc. Signs Definitive Agreement to Acquire Color Service s.r.l. (“Color Service”), a Global...
Jul 18, 2025
AXT, Inc. Announces Passing of Board Member Christine Russell
Jul 18, 2025
Westwater Resources Supports U.S. Department of Commerce Anti-Dumping Ruling on Chinese Graphite
Jul 18, 2025
Mativ Announces Conference Call to Discuss Second Quarter 2025 Results
Jul 18, 2025
Rogers Corporation Schedules Second Quarter 2025 Earnings Call for July 31
Jul 18, 2025
Utility Wins Contract Extension as Technology Provider for St. Louis Metropolitan Police Department
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events